drugset / Trial / NCT03851562
Intravenous Infusion of Prostaglandins as Therapy in Patients With Anterior Non-arteritic Ischemic Optic Neuropathy
Phase 2
Unknown
24 enrolled
Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia
RandomizedParallel-groupDouble-blindTreatment
Summary
Correction of the deficit in the perfusion pressure of the microcirculation that supplies the nerve by intravenous infusion of Prostaglandin E1 (PGE1) (Alprostadil), expected to improve visual function in patients with ischemic optic neuropathy previous non-arteritic (NOIANA).
Timeline
- Start
- 2018-06-13
- Primary completion
- 2019-06-13
- Completion
- 2019-10-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Alprostadil | Unknown | 20 ug | Intravenous |